Immune modulation of T regulatory cells and IgE responses in horses vaccinated with West Nile virus vaccine combined with a CpG ODN.

This research investigates whether adding a synthetic DNA molecule (CpG ODN) to the West Nile Virus vaccine for horses reduces the risk of allergic reactions by modifying the immune response. Giving horses this modified vaccine changed the immune response to suppress unwanted reactions, potentially offering a safer immunization option for horses with allergies.

Study Background

• The motivation behind this research was the problem of hypersensitivity reactions in horses in response to vaccines. When horses develop allergies to vaccine components, it can lead to severe reactions like hives or even deadly anaphylactic shock.
• This investigation was specifically sparked by the fact that viral vaccines often contain non-target proteins, such as bovine serum albumin (BSA). These foreign proteins can stimulate an unwanted immune response, called the production of IgE, with each subsequent vaccine dose.
• The researchers hypothesized that they could minimize this IgE response by adding a CpG oligodeoxynucleotide (ODN), a synthetic DNA molecule, to the West Nile Virus (WNV) vaccine used in horses.

Study Design and Methods

• Thirty adult horses were involved in the study. They were divided into two groups: one received the WNV vaccine with the addition of the CpG ODN, and the other received the WNV vaccine with a control GpC ODN.
• Researchers measured several factors before and after vaccination. These included the number of T regulatory cells, the concentration of BSA-specific IgE, the expression of specific proteins on PBMCs, serum concentrations of BSA-specific IgE, and concentrations of different interleukins.

Results and Findings

• Findings confirmed that adding CpG ODN to the WNV vaccine changes the immune response. Specifically, it increased the differentiation of T regulatory cells, which regulate or suppress other parts of the immune system.
• More T regulatory cells meant less BSA-specific IgE — the antibodies that contribute to allergic reactions.
• The inverse correlation between T regulatory cell numbers and serum BSA specific IgE concentrations suggests that CpG ODN stimulates regulatory cells that then suppress the animals’ allergic response to the vaccine.

Implications

• This research could provide a safer alternative vaccination strategy for horses, especially those that have already shown a propensity for allergic reactions.
• The findings could be applied in the development of vaccines to prevent hypersensitivity reactions in other animals, and potentially even humans.